ABOUT

The Pharmaceutical Solid State Research Cluster (PSSRC) was founded at the 2006 AAPS Annual Meeting in San Antonio, TX. It has since gradually expanded and now involves researchers from the universities of Cambridge (United Kingdom), Copenhagen (Denmark), Düsseldorf (Germany), Ghent (Belgium), Graz (Austria), Helsinki (Finland), Leuven (Belgium), Lille (France), Lisbon (Portugal), Ljubljana (Slovenia) and Otago (New Zealand). They have teamed up to collaborate on overcoming current limitations in the formulation of solid dosage forms. The focus of their work is on the development of novel and improve solid pharmaceutical dosage forms and strategies to ensure the quality of medicines.

The research activities in the different groups cover all areas of solid dosage form development. Current areas of particular interest are solubility enhancement and formulation, stability of medicines, physical pharmacy, and process understanding.

The cluster was formed to catalyse research activities in the solid state by sharing facilities, collaborating on specific projects and giving research students the possibility to engage with other researchers in the area.

The PSSRC receives no funding through any government or industrial sponsorships. The cluster does not sponsor any research itself. It is purely a joint platform for collaboration between the different groups and to engage with the wider community including our colleagues in industry and the regulatory agencies.

More information about PSSRC can be found at www.pssrc.org

©2020 by PSSRC